New combo attack on tough head and neck cancers
NCT ID NCT04454489
Summary
This study tested a two-part treatment for advanced head and neck cancer that had returned or spread. It combined a short, intense course of radiation with an immunotherapy drug called pembrolizumab. The goal was to see if this combination could shrink tumors and control the cancer for longer periods. The study involved 21 patients and focused on how well they responded and how long they lived without the cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
Conditions
Explore the condition pages connected to this study.